Cerebral vein thrombosis (CVT): anticoagulant treatment
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Cerebral vein thrombosis (CVT): anticoagulant treatment. Unfractionated heparin, Low molecular weight heparin (LMWH). Fully referenced neurology checklist.
Acute anticoagulation
- Unfractionated heparin
- Low molecular weight heparin (LMWH)
Short-term anticoagulation (3-6 months): indications
Locked: subscribe to see this section.
Chronic anticoagulation (6-12 months): indications
Locked: subscribe to see this section.
Indefinite anticoagulation: indications
Locked: subscribe to see this section.
Long term anticoagulation agents
Locked: subscribe to see this section.
Follow-up imaging
Locked: subscribe to see this section.
Synonym
Locked: subscribe to see this section.
References
- Saposnik G, Berinagarrementeria F, Brown Jr RD, et al. Diagnosis and management of vertebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:1158-1192.
- Saposnik G, Bushnell C, Coutinho JM, et al. Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American Heart Association. Stroke 2024 (Online ahead of print).
- Ferro JM, Bousser MG, Canhão P, et al; European Stroke Organization. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis-endorsed by the European Academy of Neurology. Eur J Neurol 2017; 24:1203-1213.
- Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:227-276.
- Rao SK, Ibrahim M, Hanni CM, et al. Apixaban for the treatment of cerebral venous thrombosis: a case series. J Neurol Sci 2017; 381:318-320.
- And 5 more. Subscribe to see the full list
